Karyopharm Therapeutics Inc

The annual 10-K, the quarterly 10-Q and the 8-K filed between them when something material happens.

1. Sep 188-KBylaws or fiscal year changed and change to shareholder rights3.035.039.01
2. Sep 118-KMaterial agreement and unregistered sale of shares1.012.043.028.019.01
3. Sep 413GPassive stake of 5% or more (13G), filed by Integrated Core Strategies (us)
4. Aug 318-KOther events8.01
5. Aug 1310-QQuarterly report
6. Aug 138-KResults of operations2.029.01
7. Jul 318-KOther events8.01
8. Jul 2813GPassive stake of 5% or more (13G), filed by BlackRock
9. Jul 178-KOfficer or director change5.02
10. May 288-KOfficer or director change and shareholder vote5.025.079.01
11. May 1410-QQuarterly report
12. May 148-KResults of operations2.029.01
13. May 4S-3Shelf registration
14. May 4S-3Shelf registration
15. Mar 278-KOther events8.01
16. Mar 248-KMaterial agreement and unregistered sale of shares1.013.027.018.019.01
17. Mar 28-KMaterial agreement and other events1.018.019.01
18. Feb 198-KShareholder vote5.07
19. Feb 1310-KAnnual report
20. Feb 128-KResults of operations2.029.01
21. Jan 128-KResults of operations and other events2.028.019.01
22. Nov 24, 2025424B3Prospectus for an offering
23. Nov 24, 2025424B3Prospectus for an offering
24. Nov 3, 2025S-3Shelf registration
25. Nov 3, 2025S-3Shelf registration
26. Nov 3, 202510-QQuarterly report
27. Nov 3, 20258-KResults of operations2.029.01
28. Oct 14, 20258-KMaterial agreement and other events1.012.038.019.01
29. Oct 8, 20258-KMaterial agreement and results of operations1.012.022.033.025.027.018.019.01
30. Sep 11, 20258-KOfficer or director change5.02
31. Aug 11, 202510-QQuarterly report
32. Aug 11, 20258-KResults of operations2.029.01